Medication Adherence During Rehabilitation: Evidence-Based Perspectives for Clinical Practice

Abstract

Medication adherence is a critical determinant of clinical outcomes during rehabilitation, impacting recovery trajectories across a spectrum of conditions including stroke, orthopedic injuries, and chronic diseases. This review synthesizes current evidence on adherence rates, underlying mechanisms, risk determinants, and practical strategies to enhance compliance in rehabilitation settings. Emphasis is placed on recent advances, guideline recommendations, and the integration of adherence-promoting interventions within multidisciplinary care models to optimize patient outcomes.

Introduction

Rehabilitation medicine frequently intersects with pharmacotherapy to restore function, prevent complications, and improve long-term prognosis. Despite the recognized benefits of medication regimens in the rehabilitation population, non-adherence remains a pervasive barrier to optimal recovery. Factors influencing adherence are multifaceted, encompassing patient beliefs, cognitive function, regimen complexity, and system-level variables. For healthcare professionals, understanding and addressing these barriers is essential for delivering high-quality, patient-centered care.

Epidemiology / Disease Burden

Non-adherence to prescribed medications in rehabilitation contexts is reported in 30-50% of patients, with substantial variation based on condition, setting, and assessment method. In post-stroke rehabilitation, studies indicate adherence rates as low as 50%, correlating strongly with secondary event risk and functional dependency. Patients recovering from orthopedic interventions, such as joint replacement, also exhibit significant non-adherence, which is associated with increased pain, delayed mobility, and higher re-hospitalization rates. The economic burden of non-adherence is considerable, contributing to avoidable readmissions and prolonged recovery.

Pathophysiology

Medication adherence in rehabilitation is influenced by both physiological and behavioral mechanisms. Cognitive deficits post-injury (e.g., after stroke or traumatic brain injury) can impair memory and executive function, directly reducing the patient’s ability to follow complex regimens. Additionally, polypharmacy increases the risk of adverse drug reactions, which may deter ongoing use. The interplay between neurological recovery, medication side effects, and functional status underscores the need for personalized adherence strategies.

Risk Factors

Multiple risk factors for poor adherence during rehabilitation have been identified. Patient-related factors include depression, cognitive impairment, low health literacy, and lack of social support. Therapy-related variables—such as regimen complexity, dosing frequency, and side effect profiles—also play a significant role. Environmental and systemic factors, including inadequate care coordination, insufficient education, and limited access to pharmacy services, further exacerbate non-adherence risk. Recognizing these determinants is crucial for targeted intervention.

Clinical Features

Clinicians may suspect poor medication adherence in rehabilitation patients presenting with suboptimal recovery, recurrent exacerbations, or unexpected complications. Warning signs include inconsistent progress in physical therapy, uncontrolled symptoms, and frequent missed appointments. Direct questioning, pill counts, and electronic monitoring can provide objective adherence data, although each method has limitations. Proactive assessment during routine follow-up enhances early identification of adherence challenges.

Diagnosis

Diagnosing medication non-adherence relies on a combination of self-report tools (e.g., Morisky Medication Adherence Scale), pharmacy refill records, and biochemical markers where available. A multidisciplinary approach, integrating input from pharmacists, nurses, and rehabilitation therapists, improves diagnostic accuracy. It is imperative to distinguish intentional non-adherence—stemming from beliefs or side effects—from unintentional lapses related to cognitive or logistical barriers, as management strategies differ accordingly.

Treatment & Management

Optimizing adherence during rehabilitation requires multifaceted intervention. Patient education—tailored to cognitive and literacy levels—serves as the cornerstone, ensuring understanding of medication purpose and regimen. Simplification of dosing schedules and use of adherence aids (e.g., pill organizers, electronic reminders) are evidence-based strategies. Regular medication reviews, involving pharmacists, allow for regimen minimization and side effect management. Motivational interviewing and involvement of family or caregivers have demonstrated efficacy, particularly in cognitively impaired populations. Close follow-up and integration of adherence evaluation into routine rehabilitation visits foster sustained compliance.

Recent Advances / Emerging Therapies

Digital health technologies, such as smartphone applications, electronic pill dispensers, and telehealth check-ins, represent promising tools to support adherence in rehabilitation settings. Recent trials have shown that personalized digital reminders and mobile health interventions can significantly improve medication-taking behaviors and clinical outcomes. Pharmacogenomic profiling is an emerging area, enabling tailored therapy selection with fewer side effects, potentially increasing adherence. Interdisciplinary rehabilitation teams are increasingly leveraging these innovations to enhance patient engagement and track progress in real time.

Guideline Recommendations

Recent clinical guidelines from organizations such as the American Heart Association and the American Academy of Physical Medicine and Rehabilitation emphasize routine assessment of medication adherence as a standard component of post-acute care. Recommendations include structured education, medication reconciliation, simplification of regimens, and use of validated adherence assessment tools. Multidisciplinary collaboration and patient-centered care planning are endorsed to address modifiable risk factors and optimize medication management throughout the rehabilitation continuum.

Conclusion

Medication adherence is integral to successful rehabilitation, with direct implications for patient recovery, functional independence, and healthcare utilization. Understanding the multifactorial contributors to non-adherence enables clinicians to implement targeted, evidence-based interventions. Advances in digital health and pharmacogenomics offer new avenues for enhancing adherence, while guideline-driven multidisciplinary strategies remain foundational. Ongoing research and clinical innovation are essential to further reduce non-adherence rates and improve outcomes for rehabilitation patients.